Search Results - "Vogt, Ulf"

Molecular targeted therapies for breast cancer treatment by Schlotter, Claus M, Vogt, Ulf, Allgayer, Heike, Brandt, Burkhard

“…Targeting the oestrogen receptor, HER2 (human epidermal growth factor receptor 2) and vascular endothelial growth factor has markedly improved breast cancer…”
Get full text

High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets by MÜLLER-TIDOW, Carsten, SCHWÄBLE, Joachim, SCHNEIDER, Paul M, BÜCHNER, Thomas, BRANDTS, Christian, BERDEL, Wolfgang E, SERVE, Hubert, STEFFEN, Björn, TIDOW, Nicola, BRANDT, Burkhardt, BECKER, Kerstin, SCHULZE-BAHR, Eric, HALFTER, Hartmut, VOGT, Ulf, METZGER, Ralf

“…Novel high-throughput analyses in molecular biology allow sensitive and rapid identification of disease-related genes and drug targets. We have used…”
Get full text

ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer by Marra, Alessandro, Kemming, Dirk, Krueer, Thomas, Bosse, Ulrich, Netchaeva, Maria, Wagner, Wolfgang, Koch, Olaf M., Vogt, Ulf, Hillejan, Ludger

“…Abstract only e18511 Background: Neoadjuvant platinum-based chemotherapy in stage III NSCLC offers the chance to eradicate occult metastases and decrease tumor…”
Get full text

Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes by Liedtke, Cornelia, Packeisen, Jens, Hess, Kenneth R, Vogt, Ulf, Kiesel, Ludwig, Kersting, Christian, Korsching, Eberhardt, Brandt, Burkhard, Buerger, Horst

“…Abstract Background Molecular breast cancer subgroups show differences with regard to prognosis and response to chemotherapy. In vitro chemotherapy sensitivity…”
Get full text

Correlation between in vitro chemotherapy sensitivity and PARP-1 expression in patients with breast cancer by Liedtke, Cornelia, Packeisen, Jens, Denkert, Carsten, Kiesel, Ludwig, Vogt, Ulf, Mueller, Berit, Hess, Kenneth R., Buerger, Horst

“…Abstract only 10627 Background: Based on its potential use as a therapeutic target through PARP inhibitors expression of Poly-A-Ribose-Polymerase-1 (PARP-1)…”
Get full text

Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival by Granetzny, Andreas, Boseila, Ahmad, Wagner, Wolfgang, Krukemeyer, Georg, Vogt, Ulf, Hecker, Erich, Koch, Olaf M., Klinke, Folker

“…Objective: Patients with small cell lung cancer (SCLC) are frequently denied surgical treatment despite growing body of evidence for a longer duration of…”
Get full text

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid by Vogt, Ulf, Bielawski, Krzysztof P, Bosse, Ulrich, Schlotter, Claus M

“…Breast cancer has a significant capacity to metastasize to bone. Bisphosphonates are the standard treatment for hypocalcaemia of malignancy (HCM), which is a…”
Get more information

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer by Schlotter, Claus M, Vogt, Ulf, Bosse, Ulrich, Mersch, Berthold, Wassmann, Katja

“…At present, node-negative, high-risk breast cancer patients cannot be identified with sufficient accuracy. Consequently, further strong prognostic factors are…”
Get full text

Cyclin A1 is highly expressed in aggressive testicular germ cell tumors by MÜLLER-TIDOW, Carsten, DIEDERICHS, Sven, SCHRADER, Mark G, VOGT, Ulf, MILLER, Kurt, BORDEL, Wolfgang E, SERVE, Hubert

“…Cyclin A1 is a tissue-specific A-type cyclin that is essential for spermatogenesis. Overexpression of cyclin A1 was found in acute myeloid leukemia and cyclin…”
Get full text

A phase II single-institution study of neoadjuvant stage III A/B chemotherapy and radiochemotherapy in non-small cell lung cancer by Granetzny, Andreas, Striehn, Eberhard, Bosse, Ulrich, Wagner, Wolfgang, Koch, Olaf, Vogt, Ulf, Froeschle, Peter, Klinke, Folker

“…The relevance of a trimodal strategy in the treatment of lung cancer, consisting of neoadjuvant radiochemotherapy followed by surgery, is a subject of ongoing…”
Get full text

A phase II single-institution study of neoadjuvant stage IIIA/b chemotherapy and radiochemotherapy in non-small cell lung cancer by GRANETZNY, Andreas, STRIEHN, Eberhard, BOSSE, Ulrich, WAGNER, Wolfgang, KOCH, Olaf, VOGT, Ulf, FROESCHLE, Peter, KLINKE, Folker

“…The relevance of a trimodal strategy in the treatment of lung cancer, consisting of neoadjuvant radiochemotherapy followed by surgery, is a subject of ongoing…”
Get full text

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer by Vogt, Ulf, Bielawski, Krzysztof, Schlotter, Claus M, Bosse, Ulrich, Falkiewicz, Bogdan, Podhajska, Anna J

“…ErbB-4 protein is a recently discovered member of the ErbB family. The role of ErbB-4 protein in mammary-gland tissue has not been definitively established. To…”
Get full text

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1 by Vogt, Ulf, Bielawski, Krzysztof, Schlotter, Claus M, Bosse, Ulrich, Falkiewicz, Bogdan, Podhajska, Anna J

Get full text

Structure and functions of ErbB (HER) receptors by Vogt, Ulf, Bielawski, Krzysztof P, Falkiewicz, Bogdan

“…The paper describes general characteristics, classification and structure of the tyrosine kinase receptor family ErbB (HER). They are encoded by two well-known…”
Get full text

Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay by Vogt, U, Falkiewicz, B, Bielawski, K, Bosse, U, Schlotter, C M

“…A pilot study on relationships of selected molecular factors [erbB-1, erbB-2, erbB-3, and c-myc oncogene average gene copy numbers (AGCN); steroid receptors…”
Get full text

Lack of squamous cell lung carcinoma in vitro chemosensitivity to various drug regimens in the adenosine triphosphate cell viability chemosensitivity assay by Vogt, U, Striehn, E, Bosse, U, Klinke, F, Falkiewicz, B

“…A pilot study on squamous cell lung carcinoma (LC) chemosensitivity in adenosine triphosphate cell viability chemosensitivity assay (ATP-CVA) was performed…”
Get full text

Anomalies of ErbB (HER) receptor functions: mechanisms and methods of detection. Part I. Gene amplification of ErbB (HER) family by Falkiewicz, Bogdan, Brandt, Burkhard H, Bielawski, Krzysztof P, Vogt, Ulf

“…The paper reviews mechanisms (gene amplifications, point mutations and deletions, gene expression alterations) leading to excessive activity of the ErbB (HER)…”
Get full text

c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer by Falkiewicz, B, Schlotter, C M, Bosse, U, Bielawski, K, Vogt, U

“…A pilot study on relationships of selected molecular factors (c-myc oncogene average gene copy numbers (AGCN); serum CEA and CA 15.3 antigen levels; tumor…”
Get full text

Direct-double-differential PCR for gene dosage quantification of c-myc by BECKMANN, A, VOGT, U, HUDA, N, ZÄNKER, K. S, BRANDT, B. H

Get full text